Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On Post author:Sam Post published:November 15, 2017 Post category:BioPharma Teva’s stock jumped as investors get more hopeful about the future. Source: BioSpace You Might Also Like Akonni Biosystems Release: Company Strengthens Leadership Team With Multiple Key Appointments January 24, 2017 Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest November 29, 2017 Alimera Sciences To Report Second Quarter 2017 Financial Results On August 2nd, 2017 July 23, 2017
Akonni Biosystems Release: Company Strengthens Leadership Team With Multiple Key Appointments January 24, 2017
